This site is intended for healthcare professionals only
LoginRegister
Side effects of COVID vaccine: BioNTech faces first German lawsuitSide effects of COVID vaccine: BioNTech faces first German lawsuit
NPPA Fixes Ceiling Price Of 15 Scheduled Formulations, DetailsNPPA Fixes Ceiling Price Of 15 Scheduled Formulations, Details
Eris Lifesciences Slapped Rs 17 Crore GST Notice Over Novartis Zomelis DealEris Lifesciences Gets CDSCO Panel Nod To Manufacture, Market PCOS drug combination
U S government sets penalties on 43 drugs over price hikesU S government sets penalties on 43 drugs over price hikes
Eisai seeks marketing nod for Lecanemab for early Alzheimers disease treatment in South KoreaEisai seeks marketing nod for Lecanemab for early Alzheimer's disease treatment in South Korea
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb gets USFDA nod for commercial production at newest Devens cell therapy...
Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy productAstraZeneca, Quell Therapeutics ink pact for engineered T-regulatory cell therapies for autoimmune...
Abbott to Conduct BE Study for Carbimazole 15 mg, Trial Waiver Granted In IndiaCDSCO Panel Rejects Abbott Healthcare's Proposal To Waive Local CT of Clarithromycin ER Tablets
Micro Labs Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC DrugMicro Labs Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug
Kerala CM holds talks with Pfizer over opening of research centre in KeralaKerala CM holds talks with Pfizer over opening of research centre in Kerala
Zydus gets USFDA nod for bowel disease drug Balsalazide DisodiumZydus gets USFDA nod for bowel disease drug Balsalazide Disodium
USFDA advisory committee votes unanimously to confirm clinical benefit of Leqembi for Alzheimers DiseaseUSFDA advisory committee votes unanimously to confirm clinical benefit of Leqembi for Alzheimer's...
X